Cooling and heating is provided for a wide array of different end-uses. These include, but are not limited in application to, the food industry (from farming, to food preparation, to food service), automotive, marine, and recreational vehicles, residential and commercial HVAC, manufacturing and fabrication, the military, and medical applications. Most cooling and heating systems involve heat transfer. That is, either heat is added or removed to provide the desired heating or cooling respectively.
A cooling and heating platform is disclosed. In an example, the cooling and heating platform may be implemented as a cooling and heating platform that is inherently operating at a selected temperature, controlled via vacuum, hygroscopic, electrostatic system(s), and/or a heating element, e.g., in a combinatory manner. The cooling and heating platform may provide a scalable chilling and heating solution. The cooling and heating platform may be implemented in a wide variety of cooling, refrigeration, and/or heating applications.
In an example, the cooling and heating platform manages pressure within an operating chamber to maintain a steady operating temperature based on the boiling point of an “operating liquid.” In an example, the operating liquid is an inexpensive and environmentally friendly “refrigerant.”
By way of illustration, the refrigerant may be water-based and thus ecologically-friendly. An example water-based refrigerant includes, but is not limited to, distilled water. However, other operating liquids may also be implemented. Configurations utilizing a variety of other operating liquids can operate in different temperature ranges, allowing for heating and chilling solutions for an expanded range of applications.
Unlike standard refrigeration or ice, the example cooling and heating platform provides chilling to a specific temperature. The cooling and heating platform is not limited to extreme chilling that requires external control to achieve the desired temperature. This is a particularly important aspect in applications such as, but not limited to, physical therapy. In physical therapy, using too cold of a temperature (e.g., freezing) can have adverse health effects.
The cooling and heating platform is a viable replacement for many chilling/refrigeration devices that are based on the use of standard refrigerants (e.g., CFC's and their replacements). As such, cooling technologies based on the cooling platform may be implemented to reduce the climate impacts from world-wide use of CFC's and their replacements.
Before continuing, it is noted that as used herein, the terms “includes” and “including” mean, but is not limited to, “includes” or “including” and “includes at least” or “including at least.” The term “based on” means “based on” and “based at least in part on.”
The term “operating liquid” means any suitable matter to absorb energy via change of phase. The term “operating chamber” means any suitable partially or fully sealed vessel or container that houses a phase-change mechanism.
The term “heat exchanger” means a device used to transfer heat from one medium to another.
The term “application interface” means any mechanism that enables the transfer of thermal energy between the cooling/heating platform and an application that utilizes the heating/cooling provided by the platform. This may include but is not limited to an “application fluid” that physically transfers heat by flowing or circulating through a heat exchanger and the application.
In addition, the term “thermal battery” as used herein means any suitable device or matter to store thermal energy. A thermal battery, e.g. additional operating liquid, provides the ability to satisfy burst chilling/heating requirements that exceed the instantaneous capacity of the device.
The term “operating liquid supply” means a device that adds operating liquid to the operating chamber.
The term “hygroscopic material” means a material that adsorbs operating liquid vapor from the platform, e.g., from the operating chamber.
The term “electrostatic device” means a device that causes operating liquid vapor atoms/molecules to move in a desired path due to electrostatic fields, e.g., attracting ionized vapor to a anode or cathode for removal from the operating chamber.
The term “bypass switch” means a device that reroutes application fluid depending on the mode selected by the user.
The term “control system” means a system that monitors performance, maintains, displays and/or records the state, and controls the platform relative to a desired mode selected by the user.
The term “overpressure” means pressure above ambient atmospheric pressure.
The example cooling and heating platform 10 also includes an operating liquid supply 22. Example configurations of the cooling and heating platform 10 may include a total load of operating liquid 18, e.g., to sustain operation through a nominal operational period.
The operating liquid supply 22 may include a mechanism to reload and restart the device (e.g., open, refill, and then reestablish vacuum).
In another example, operating liquid 18 can be added during operation by introducing operating liquid 18 from the operating liquid supply 22 (e.g., an external source) directly into the operating chamber 12 without breaking vacuum.
Example implementations may include at least one sensor 24, e.g. temperature, pressure, or operating liquid level, on the interior of the operating chamber 12. A vapor removal mechanism 26 may be provided. A fluid circulating pump 28 may be provided to move the application fluid through the heat exchanger 20.
The cooling and heating platform 10 may be configured with one or more connectors that provide access to heat exchanger 20. The connectors may be commercially available (e.g., standard water hose connection), or specifically designed to a particular application. A pressure management device 32, e.g. a vacuum pump, and an operating liquid recovery mechanism 52 may be provided.
Control connections may be provided to control the pressure management device and operating liquid recovery mechanism 52 based on feedback from at least one sensor 24 for the operating chamber 12 and/or for the application 30 to a control system 40 to orchestrate any/all elements of the platform.
The cooling and heating platform 10 can be incorporated into any application 30 that utilizes traditional chilling/refrigeration, and can also be configured to support a wide range of cooling and heating applications. The cooling and heating platform also supports many, if not most, everyday chilling/refrigeration applications 30 and a range of cooling and/or heating applications 30. Examples of applications 30 include, but are not limited to an in-line fluid cooler/heater and a portable cold storage device
An in-line fluid cooler/heater may have application to the following:
A portable cold storage device may have application to the outdoor recreation (boating, RV, hunting, camping, etc.) industry—Consumers want convenience and good products to enjoy their outdoor activities. During recreational activities, people are always running for more ice. Current built in boat coolers only hold ice for a few hours. With the cooling system retrofitted into an existing built-in cooler or incorporated into new cooler designs, purchasing a premium cooler will no longer be necessary.
A vacuum-based version as detailed above may have application to the following:
A version for manufacturing-based industries may have application to the following (e.g., for equipment and process cooling):
A food service version may have application to the following:
A medical or therapy-based version may have application to the medical (inpatient/outpatient, sports/physical therapy, etc.)—since the main premise in medicine is all about healing, the medical industry actively seeks faster recovery times in order to improve healing success rates. The device provides hot and cold therapy at therapeutic temperatures within specific limits determined to be medically safe.
A transportation-based version may have application to the following:
Example configurations of the cooling and heating platform 10 may be provided for different operating temperatures to support other chilling and/or heating applications. The operating liquid 18 may be selected based on design considerations, such as but not limited to, optimizing the ability to maintain the target operating temperature required for the application. Other considerations may include, but are not limited to, the pressure/vacuum and environmental/safety considerations of the operating liquid 18.
In an example, the cooling and heating platform 10 may be portable (e.g., hand carried), semi-portable (e.g., movable with the assistance of a hand truck, or similar), or fixed (e.g., requiring heavy equipment to be moved).
Example operation of the cooling and heating platform 10 is based on maintaining the pressure in a chamber or other vessel 12 containing the operating liquid 18 at a level of vacuum/overpressure (e.g., from pressure management device 32 and operating liquid recovery mechanism 52) such that the boiling point of the operating liquid 18 corresponds to the target chilling (or heating) temperature of the device or application 30. Chilling/refrigeration is provided by passing an application fluid to be chilled or heated (e.g., within return line 34) through a heat exchanger 20 (e.g., coils) immersed in the operating liquid 18 within the operating chamber 12 and to the application 30 (e.g., via supply line 38).
For the chilling configuration, having water as the operating liquid 18 in the operating chamber 12, the level of vacuum may be maintained by mechanical pumping and/or, for example, the use of hygroscopic materials, such as but not limited to these two, or similar mechanisms that remove water vapor from the operating chamber 12.
The chilling capacity of the cooling and heating platform 10 is determined primarily by the heat exchanger implementation and the capacity of the cooling and heating platform 10 for removing operating liquid vapor from the operating chamber 12. The platform may be configured to maintain the operating liquid in its liquid state in order to maximize the mixing effect of boiling, but configurations cause the operating liquid to change state to solid are also possible. Phase change of the subsequent solid form of the operating liquid back to liquid form (melting) and/or vapor (sublimation) may be incorporated into the operation of the platform.
For applications that require higher chilling capacities in bursts, the device may include a thermal battery 16 of additional operating liquid and/or other material(s) with suitable heat capacity that increases the heat capacity of the operating chamber 12 to the level desired to support the thermal load from burst chilling/heating. The normal chilling/heating function of the operating chamber 12 recharges the thermal battery 16 between bursts. The thermal battery may be located within the operating chamber 12 or externally.
The overall device behavior can be controlled with device control system 40 based on inputs from the device or application including, but not limited to, temperature, pressure, flow, and/or other sensors. The device control system 40 can operate attached devices, e.g., pressure management device 32, bypass switch 46, circulating pump 28, and operating liquid supply 22.
Operating chamber 12 is connected to pressure management device 32 through vacuum line 45.
For configurations where the operating chamber 12 is providing cooling, the heating bypass mechanism 46 can direct the application fluid to bypass the operating chamber 12 and pass through a heating element either integrated or external to heating bypass mechanism 46. This permits a single device to support heating and cooling applications separately or cyclically when alternating heating/cooling cycles are desired.
Before continuing, it should be noted that the examples described above for
The example configuration of the cooling and heating platform 10 shown in
In addition, the example cooling and heating platform 10 shown in
In an example, the vapor removal system 50 includes hygroscopic material for removal of water vapor. Another example is where a vapor removal mechanism utilizes an electrostatic approach, similar to removing particulates from power plant and other exhausts (e.g., where the operating liquid 18 is not water-based).
Various configurations of the cooling and heating platform may permit recharging, reloading, and/or replacing vapor removal material in the vapor removal mechanism 50. The vapor removal material may include hygroscopic materials or their equivalent in non-water based configurations. An example vapor removal mechanism 50 may include the mechanical replacement of a “cartridge” containing the vapor removal material. Another example vapor removal mechanism 50 may include a mechanism to add additional fresh material to the liquid recovery system 52. An example vapor removal mechanism 50 may also include mechanism that seals a cartridge or other container of the liquid recovery system 52 from the operating chamber 12. The vapor removal material may be exposed to the atmosphere and then dried (e.g., via a heater, or some other method that is tailored to the specific material used in the configuration).
The operations shown and described herein are provided to illustrate example implementations. It is noted that the operations are not limited to the ordering shown. Still other operations may also be implemented.
In an example, the physical therapy application 130 may include a therapy wrap (e.g., to be placed on a body, such as an ankle wrap). The cycling chiller/heater platform 110 may be operatively associated with a controller 102 for the therapy wrap. The controller may include control electronics and/or software to implement a thermal control and circulating pump.
The cycling chiller/heater platform 110 may receive feedback 104 from the controller 102. The feedback can be utilized to control temperature to the therapy application 130. Fluid output lines 106a-b deliver the temperature controlled application fluid to the physical therapy application 130 (e.g., the ankle wrap). Fluid return or input lines 108a-b return the application fluid to the chiller platform 110 to maintain the desired temperature.
Of course, the example shown and described with reference to
It is noted that the examples shown and described are provided for purposes of illustration and are not intended to be limiting. Still other examples are also contemplated.
This application claims the benefit of U.S. Provisional Patent Application No. 62/321,887 filed Apr. 13, 2016 titled “Cooling and Heating Platform” of Hepp, et al., hereby incorporated by reference in its entirety as though full set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
1886768 | Watson | Nov 1932 | A |
1958899 | MacAdams | May 1934 | A |
2146622 | Simon | Feb 1939 | A |
2413386 | Schulz | Dec 1946 | A |
2510125 | Meakin | Jun 1950 | A |
2531074 | Miller | Nov 1950 | A |
2540547 | Rodert | Feb 1951 | A |
2608690 | Kolb et al. | Sep 1952 | A |
2703770 | Melzer | Mar 1955 | A |
2726658 | Chessey | Dec 1955 | A |
2954898 | Freeberg | Oct 1960 | A |
3261042 | Baker | Jul 1966 | A |
3320682 | Sliman | May 1967 | A |
3354898 | Barnes | Nov 1967 | A |
3470943 | Van Huisen | Oct 1969 | A |
3561435 | Nicholson | Feb 1971 | A |
3738367 | Hardy | Jun 1973 | A |
3744555 | Fletcher et al. | Jul 1973 | A |
3830676 | Elkins | Aug 1974 | A |
3871381 | Roslonski | Mar 1975 | A |
3901225 | Sconce | Aug 1975 | A |
3993053 | Grossan | Nov 1976 | A |
4009587 | Robinson, Jr. | Mar 1977 | A |
4020209 | Yuan | Apr 1977 | A |
4026299 | Sauder | May 1977 | A |
4116476 | Porter et al. | Sep 1978 | A |
4118946 | Tubin | Oct 1978 | A |
4147921 | Walter et al. | Apr 1979 | A |
4149529 | Copeland et al. | Apr 1979 | A |
4149541 | Gammons et al. | Apr 1979 | A |
4170998 | Sauder | Oct 1979 | A |
4184537 | Sauder | Jan 1980 | A |
4194247 | Melander | Mar 1980 | A |
4335726 | Kolstedt | Jun 1982 | A |
4338944 | Arkans | Jul 1982 | A |
4375831 | Downing, Jr. | Mar 1983 | A |
D269379 | Bledsoe | Jun 1983 | S |
4407276 | Bledsoe | Oct 1983 | A |
4412648 | Ford et al. | Nov 1983 | A |
4436125 | Blenkush | Mar 1984 | A |
4460085 | Jantzen | Jul 1984 | A |
4463751 | Bledsoe | Aug 1984 | A |
4466253 | Jaster | Aug 1984 | A |
4471759 | Anderson et al. | Sep 1984 | A |
4478436 | Hashimoto | Oct 1984 | A |
4547906 | Nishida et al. | Oct 1985 | A |
4550828 | Baldwin et al. | Nov 1985 | A |
4556457 | McCord | Dec 1985 | A |
4597384 | Whitney | Jul 1986 | A |
4678027 | Shirey et al. | Jul 1987 | A |
4691762 | Elkins et al. | Sep 1987 | A |
4699613 | Donawick et al. | Oct 1987 | A |
4718429 | Smidt | Jan 1988 | A |
4738119 | Zafred | Apr 1988 | A |
4753268 | Palau | Jun 1988 | A |
4765338 | Turner et al. | Aug 1988 | A |
4817588 | Bledsoe | Apr 1989 | A |
4834073 | Bledsoe et al. | May 1989 | A |
4844072 | French et al. | Jul 1989 | A |
4884304 | Elkins | Dec 1989 | A |
4925603 | Nambu | May 1990 | A |
4955369 | Bledsoe et al. | Sep 1990 | A |
4955435 | Shuster et al. | Sep 1990 | A |
4962761 | Golden | Oct 1990 | A |
4964282 | Wagner | Oct 1990 | A |
4964402 | Grim et al. | Oct 1990 | A |
4966145 | Kikumoto et al. | Oct 1990 | A |
4976262 | Palmacci | Dec 1990 | A |
4996970 | Legare | Mar 1991 | A |
5002270 | Shine | Mar 1991 | A |
5014695 | Benak et al. | May 1991 | A |
5022109 | Pekar | Jun 1991 | A |
5033136 | Elkins | Jul 1991 | A |
5052725 | Meyer et al. | Oct 1991 | A |
5056563 | Glossop | Oct 1991 | A |
5072875 | Zacoi | Dec 1991 | A |
5074285 | Wright | Dec 1991 | A |
5076068 | Mikhail | Dec 1991 | A |
5080089 | Mason et al. | Jan 1992 | A |
5080166 | Haugeneder | Jan 1992 | A |
5086771 | Molloy | Feb 1992 | A |
5097829 | Quisenberry | Mar 1992 | A |
5104158 | Meyer et al. | Apr 1992 | A |
5112045 | Mason et al. | May 1992 | A |
5113877 | Johnson, Jr. et al. | May 1992 | A |
5163425 | Nambu et al. | Nov 1992 | A |
5163923 | Donawick et al. | Nov 1992 | A |
5172689 | Wright | Dec 1992 | A |
5186698 | Mason et al. | Feb 1993 | A |
5201552 | Hohmann et al. | Apr 1993 | A |
5230335 | Johnson, Jr. et al. | Jul 1993 | A |
5232020 | Mason et al. | Aug 1993 | A |
5241951 | Mason et al. | Sep 1993 | A |
5243706 | Frim et al. | Sep 1993 | A |
5269369 | Faghri | Dec 1993 | A |
D345609 | Mason et al. | Mar 1994 | S |
5294156 | Kumazaki et al. | Mar 1994 | A |
D345802 | Mason et al. | Apr 1994 | S |
D345803 | Mason et al. | Apr 1994 | S |
5303716 | Mason et al. | Apr 1994 | A |
5305712 | Goldstein | Apr 1994 | A |
5314455 | Johnson, Jr. et al. | May 1994 | A |
5316250 | Mason et al. | May 1994 | A |
5316547 | Gildersleeve | May 1994 | A |
D348106 | Mason et al. | Jun 1994 | S |
5324319 | Mason et al. | Jun 1994 | A |
D348518 | Mason et al. | Jul 1994 | S |
D351472 | Mason et al. | Oct 1994 | S |
5352174 | Mason et al. | Oct 1994 | A |
5353605 | Naaman | Oct 1994 | A |
5354101 | Anderson, Jr. | Oct 1994 | A |
5354103 | Torrence et al. | Oct 1994 | A |
D352781 | Mason et al. | Nov 1994 | S |
5372575 | Sebastian | Dec 1994 | A |
5383689 | Wolfe | Jan 1995 | A |
RE34883 | Grim | Mar 1995 | E |
5395399 | Rosenwald | Mar 1995 | A |
5407421 | Goldsmith | Apr 1995 | A |
5411541 | Bell et al. | May 1995 | A |
5415625 | Cassford et al. | May 1995 | A |
5417720 | Mason | May 1995 | A |
5427577 | Picchietti et al. | Jun 1995 | A |
5441533 | Johnson et al. | Aug 1995 | A |
5449379 | Hadtke | Sep 1995 | A |
5451201 | Prengler | Sep 1995 | A |
5466250 | Johnson, Jr. et al. | Nov 1995 | A |
5470353 | Jensen | Nov 1995 | A |
5476489 | Koewler | Dec 1995 | A |
5484448 | Steele et al. | Jan 1996 | A |
5494074 | Ramacier, Jr. et al. | Feb 1996 | A |
5496358 | Rosenwald | Mar 1996 | A |
5507792 | Mason et al. | Apr 1996 | A |
5509894 | Mason et al. | Apr 1996 | A |
5514081 | Mann | May 1996 | A |
5520622 | Bastyr et al. | May 1996 | A |
5524293 | Kung | Jun 1996 | A |
5527268 | Gildersleeve et al. | Jun 1996 | A |
5533354 | Pirkle | Jul 1996 | A |
5539934 | Ponder | Jul 1996 | A |
D372534 | Andrews et al. | Aug 1996 | S |
5553712 | Tisbo et al. | Sep 1996 | A |
5554119 | Harrison et al. | Sep 1996 | A |
5556138 | Nakajima et al. | Sep 1996 | A |
5564124 | Elsherif et al. | Oct 1996 | A |
5569172 | Padden et al. | Oct 1996 | A |
5592694 | Yewer, Jr. | Jan 1997 | A |
5593426 | Morgan et al. | Jan 1997 | A |
5630328 | Hise et al. | May 1997 | A |
5634886 | Bennett | Jun 1997 | A |
5634940 | Panyard | Jun 1997 | A |
5638707 | Gould | Jun 1997 | A |
5645671 | Tillinghast | Jul 1997 | A |
D382113 | DuRapau | Aug 1997 | S |
5653741 | Grant | Aug 1997 | A |
D383547 | Mason et al. | Sep 1997 | S |
D383848 | Mason et al. | Sep 1997 | S |
5662239 | Heuvelman | Sep 1997 | A |
5662695 | Mason et al. | Sep 1997 | A |
5672152 | Mason et al. | Sep 1997 | A |
5683118 | Slocum | Nov 1997 | A |
5728058 | Ouellette et al. | Mar 1998 | A |
5732464 | Lamont | Mar 1998 | A |
5755275 | Rose et al. | May 1998 | A |
5755755 | Panyard | May 1998 | A |
5772618 | Mason et al. | Jun 1998 | A |
5782780 | Mason et al. | Jul 1998 | A |
5792216 | Kappel | Aug 1998 | A |
5807294 | Cawley et al. | Sep 1998 | A |
5827208 | Mason et al. | Oct 1998 | A |
5833638 | Nelson | Nov 1998 | A |
5862675 | Scaringe et al. | Jan 1999 | A |
5865841 | Kolen et al. | Feb 1999 | A |
5866219 | McClure et al. | Feb 1999 | A |
5868690 | Eischen | Feb 1999 | A |
5871526 | Gibbs et al. | Feb 1999 | A |
5895418 | Saringer | Apr 1999 | A |
5913885 | Klatz et al. | Jun 1999 | A |
5920934 | Hannagan et al. | Jul 1999 | A |
5951598 | Bishay et al. | Sep 1999 | A |
5967225 | Jenkins | Oct 1999 | A |
5968072 | Hite et al. | Oct 1999 | A |
5970519 | Weber | Oct 1999 | A |
5980561 | Kolen et al. | Nov 1999 | A |
5984885 | Gaylord, Jr. et al. | Nov 1999 | A |
5989285 | DeVilbiss et al. | Nov 1999 | A |
5992459 | Sugita et al. | Nov 1999 | A |
5997495 | Cook et al. | Dec 1999 | A |
6030412 | Klatz et al. | Feb 2000 | A |
6036107 | Aspen et al. | Mar 2000 | A |
6036718 | Ledford et al. | Mar 2000 | A |
6048326 | Davis et al. | Apr 2000 | A |
6053169 | Hunt | Apr 2000 | A |
6055670 | Parker | May 2000 | A |
6074413 | Davis et al. | Jun 2000 | A |
6083256 | Ovanesian | Jul 2000 | A |
D430288 | Mason et al. | Aug 2000 | S |
D430289 | Mason et al. | Aug 2000 | S |
6105382 | Reason | Aug 2000 | A |
6109338 | Butzer | Aug 2000 | A |
6117164 | Gildersleeve et al. | Sep 2000 | A |
6146413 | Harman | Nov 2000 | A |
6156059 | Olofsson | Dec 2000 | A |
6178562 | Elkins | Jan 2001 | B1 |
6197045 | Carson | Mar 2001 | B1 |
6228106 | Simbruner et al. | May 2001 | B1 |
6238427 | Matta | May 2001 | B1 |
6260890 | Mason | Jul 2001 | B1 |
6261314 | Rich | Jul 2001 | B1 |
6270481 | Mason et al. | Aug 2001 | B1 |
6306112 | Bird | Oct 2001 | B2 |
6328276 | Falch et al. | Dec 2001 | B1 |
6352550 | Gildersleeve et al. | Mar 2002 | B1 |
6354635 | Dyson et al. | Mar 2002 | B1 |
6361514 | Brown et al. | Mar 2002 | B1 |
6368357 | Schon et al. | Apr 2002 | B1 |
6371976 | Vrzalik et al. | Apr 2002 | B1 |
6382678 | Field et al. | May 2002 | B1 |
6398748 | Wilson | Jun 2002 | B1 |
6405080 | Lasersohn et al. | Jun 2002 | B1 |
6406445 | Ben-Nun | Jun 2002 | B1 |
6440159 | Edwards et al. | Aug 2002 | B1 |
6443498 | Liao | Sep 2002 | B1 |
6508831 | Kushnir | Jan 2003 | B1 |
6547284 | Rose et al. | Apr 2003 | B2 |
6551264 | Cawley et al. | Apr 2003 | B1 |
6551347 | Elkins | Apr 2003 | B1 |
6551348 | Blalock et al. | Apr 2003 | B1 |
6616620 | Sherman et al. | Sep 2003 | B2 |
6620187 | Carson et al. | Sep 2003 | B2 |
6641601 | Augustine et al. | Nov 2003 | B1 |
6645232 | Carson | Nov 2003 | B2 |
6660027 | Gruszecki et al. | Dec 2003 | B2 |
D486870 | Mason | Feb 2004 | S |
6692518 | Carson | Feb 2004 | B2 |
6695872 | Elkins | Feb 2004 | B2 |
6699267 | Voorhees et al. | Mar 2004 | B2 |
6719713 | Mason | Apr 2004 | B2 |
6719728 | Mason et al. | Apr 2004 | B2 |
6802823 | Mason | Oct 2004 | B2 |
6818012 | Ellingboe | Nov 2004 | B2 |
6823682 | Jenkins et al. | Nov 2004 | B1 |
6871878 | Miros | Mar 2005 | B2 |
6893414 | Goble et al. | May 2005 | B2 |
6926311 | Chang et al. | Aug 2005 | B2 |
6932304 | Villamar | Aug 2005 | B1 |
6936019 | Mason | Aug 2005 | B2 |
6942015 | Jenkins | Sep 2005 | B1 |
6961611 | Dupelle | Nov 2005 | B2 |
7001417 | Elkins | Feb 2006 | B2 |
7008445 | Lennox | Mar 2006 | B2 |
7017213 | Chisari | Mar 2006 | B2 |
7025709 | Riggall | Apr 2006 | B2 |
7044960 | Voorhees et al. | May 2006 | B2 |
7052509 | Lennox et al. | May 2006 | B2 |
7059329 | Mason et al. | Jun 2006 | B2 |
7060045 | Mason et al. | Jun 2006 | B2 |
7060086 | Wilson et al. | Jun 2006 | B2 |
7093903 | O'Connor et al. | Aug 2006 | B2 |
7107629 | Miros et al. | Sep 2006 | B2 |
7108664 | Mason et al. | Sep 2006 | B2 |
7117569 | Bledsoe | Oct 2006 | B2 |
7125417 | Mizrahi | Oct 2006 | B2 |
7141131 | Foxen et al. | Nov 2006 | B2 |
7156054 | York | Jan 2007 | B1 |
7166083 | Bledsoe | Jan 2007 | B2 |
7191798 | Edelman et al. | Mar 2007 | B2 |
7198093 | Elkins | Apr 2007 | B1 |
7235059 | Mason et al. | Jun 2007 | B2 |
7244239 | Howard | Jul 2007 | B2 |
7306568 | Diana | Dec 2007 | B2 |
7308304 | Hampton et al. | Dec 2007 | B2 |
7326196 | Olsen et al. | Feb 2008 | B2 |
7361186 | Voorhees et al. | Apr 2008 | B2 |
7418755 | Bledsoe et al. | Sep 2008 | B2 |
7434844 | Kao | Oct 2008 | B2 |
7448653 | Jensen et al. | Nov 2008 | B2 |
7479122 | Ceriani et al. | Jan 2009 | B2 |
7485103 | Mason et al. | Feb 2009 | B2 |
7490620 | Tesluk et al. | Feb 2009 | B2 |
7500957 | Bledsoe | Mar 2009 | B2 |
7640764 | Gammons et al. | Jan 2010 | B2 |
7658205 | Edelman et al. | Feb 2010 | B1 |
7694693 | Edelman et al. | Apr 2010 | B1 |
7731244 | Miros et al. | Jun 2010 | B2 |
7785283 | Bledsoe | Aug 2010 | B1 |
7797044 | Covey et al. | Sep 2010 | B2 |
7837638 | Miros et al. | Nov 2010 | B2 |
7864941 | Bledsoe et al. | Jan 2011 | B1 |
7871427 | Dunbar et al. | Jan 2011 | B2 |
7896910 | Schirrmacher et al. | Mar 2011 | B2 |
7908692 | Lange | Mar 2011 | B2 |
7914563 | Mason et al. | Mar 2011 | B2 |
7959588 | Wolpa | Jun 2011 | B1 |
7959657 | Harsy | Jun 2011 | B1 |
7988653 | Fout et al. | Aug 2011 | B2 |
8052628 | Edelman et al. | Nov 2011 | B1 |
8066752 | Hamilton et al. | Nov 2011 | B2 |
8109273 | Golden et al. | Feb 2012 | B2 |
8121681 | Hampton et al. | Feb 2012 | B2 |
8182521 | Kane et al. | May 2012 | B2 |
8216163 | Edelman | Jul 2012 | B2 |
8216290 | Shawver et al. | Jul 2012 | B2 |
8216398 | Bledsoe et al. | Jul 2012 | B2 |
8226698 | Edelman et al. | Jul 2012 | B2 |
8251932 | Fout | Aug 2012 | B2 |
8251936 | Fout et al. | Aug 2012 | B2 |
8273045 | Ceriani | Sep 2012 | B2 |
8277403 | Ceriani et al. | Oct 2012 | B2 |
8328742 | Bledsoe | Dec 2012 | B2 |
8397518 | Vistakula | Mar 2013 | B1 |
8414512 | Fout | Apr 2013 | B2 |
8419670 | Downing | Apr 2013 | B2 |
8425579 | Edelman et al. | Apr 2013 | B1 |
8444581 | Maxon-Maldonado et al. | May 2013 | B1 |
8512263 | Gammons | Aug 2013 | B2 |
8613762 | Bledsoe | Dec 2013 | B2 |
9066781 | Muehlbauer et al. | Jun 2015 | B2 |
9345614 | Schaefer et al. | May 2016 | B2 |
9402763 | Bledsoe | Aug 2016 | B2 |
9566187 | Edelman et al. | Feb 2017 | B2 |
10426655 | Schaefer et al. | Oct 2019 | B2 |
20010018604 | Elkins | Aug 2001 | A1 |
20010034545 | Elkins | Oct 2001 | A1 |
20010034546 | Elkins | Oct 2001 | A1 |
20010039439 | Elkins et al. | Nov 2001 | A1 |
20020019657 | Elkins | Feb 2002 | A1 |
20020026226 | Ein | Feb 2002 | A1 |
20020032473 | Kushnir et al. | Mar 2002 | A1 |
20020041621 | Faries et al. | Apr 2002 | A1 |
20020058975 | Bieberich | May 2002 | A1 |
20020082668 | Ingman | Jun 2002 | A1 |
20020093189 | Krupa | Jul 2002 | A1 |
20020108279 | Hubbard et al. | Aug 2002 | A1 |
20020184784 | Strzala | Dec 2002 | A1 |
20030060761 | Evans et al. | Mar 2003 | A1 |
20030196352 | Bledsoe et al. | Oct 2003 | A1 |
20040064170 | Radons et al. | Apr 2004 | A1 |
20040064171 | Briscoe et al. | Apr 2004 | A1 |
20040068309 | Edelman | Apr 2004 | A1 |
20040158303 | Lennox et al. | Aug 2004 | A1 |
20040162587 | Hampton et al. | Aug 2004 | A1 |
20040167594 | Elkins | Aug 2004 | A1 |
20040210283 | Rose et al. | Oct 2004 | A1 |
20040225341 | Schock et al. | Nov 2004 | A1 |
20040243202 | Lennox | Dec 2004 | A1 |
20050107855 | Lennox et al. | May 2005 | A1 |
20050126578 | Garrison et al. | Jun 2005 | A1 |
20050131324 | Bledsoe | Jun 2005 | A1 |
20050136213 | Seth et al. | Jun 2005 | A1 |
20050143796 | Augustine et al. | Jun 2005 | A1 |
20050143797 | Parish et al. | Jun 2005 | A1 |
20060058858 | Smith | Mar 2006 | A1 |
20060144557 | Koscheyev et al. | Jul 2006 | A1 |
20060156761 | Mola | Jul 2006 | A1 |
20060190062 | Worthen | Aug 2006 | A1 |
20060200057 | Sterling | Sep 2006 | A1 |
20060287697 | Lennox | Dec 2006 | A1 |
20070060987 | Grahn et al. | Mar 2007 | A1 |
20070108829 | Lehn et al. | May 2007 | A1 |
20070118194 | Mason et al. | May 2007 | A1 |
20070118965 | Hoffman | May 2007 | A1 |
20070157931 | Parker et al. | Jul 2007 | A1 |
20070161932 | Pick et al. | Jul 2007 | A1 |
20070161933 | Ravikumar | Jul 2007 | A1 |
20070167895 | Gramza et al. | Jul 2007 | A1 |
20070191918 | Machold et al. | Aug 2007 | A1 |
20070282230 | Valderrabano et al. | Dec 2007 | A1 |
20080000474 | Jochle et al. | Jan 2008 | A1 |
20080058911 | Parish et al. | Mar 2008 | A1 |
20080065172 | Magdych | Mar 2008 | A1 |
20080067095 | Mueller | Mar 2008 | A1 |
20080077211 | Levinson et al. | Mar 2008 | A1 |
20080097560 | Radziunas et al. | Apr 2008 | A1 |
20080097561 | Melsky et al. | Apr 2008 | A1 |
20080114406 | Hampton et al. | May 2008 | A1 |
20080132816 | Kane et al. | Jun 2008 | A1 |
20080132976 | Kane et al. | Jun 2008 | A1 |
20080161891 | Pierre et al. | Jul 2008 | A1 |
20080176199 | Stickney et al. | Jul 2008 | A1 |
20080188915 | Mills et al. | Aug 2008 | A1 |
20080234788 | Wasowski | Sep 2008 | A1 |
20080249593 | Cazzini et al. | Oct 2008 | A1 |
20080269852 | Lennox et al. | Oct 2008 | A1 |
20080275534 | Noel | Nov 2008 | A1 |
20080283426 | Primer et al. | Nov 2008 | A1 |
20090005841 | Schirrmacher et al. | Jan 2009 | A1 |
20090018623 | Levinson et al. | Jan 2009 | A1 |
20090038195 | Riker et al. | Feb 2009 | A1 |
20090062890 | Ugajin et al. | Mar 2009 | A1 |
20090069731 | Parish et al. | Mar 2009 | A1 |
20090183410 | Tursso et al. | Jul 2009 | A1 |
20090270930 | Walker et al. | Oct 2009 | A1 |
20100006631 | Edwards et al. | Jan 2010 | A1 |
20100076531 | Beran et al. | Mar 2010 | A1 |
20100121392 | Stickney et al. | May 2010 | A1 |
20100137951 | Lennox et al. | Jun 2010 | A1 |
20100139294 | Lowe et al. | Jun 2010 | A1 |
20100145421 | Tomlinson et al. | Jun 2010 | A1 |
20100161013 | Heaton | Jun 2010 | A1 |
20100217349 | Fahey | Aug 2010 | A1 |
20100241120 | Bledsoe et al. | Sep 2010 | A1 |
20100318143 | Chapman et al. | Dec 2010 | A1 |
20110004132 | Cook | Jan 2011 | A1 |
20110028873 | Miros et al. | Feb 2011 | A1 |
20110040359 | Harris et al. | Feb 2011 | A1 |
20110046700 | McDonald et al. | Feb 2011 | A1 |
20110048049 | Asai | Mar 2011 | A1 |
20110087142 | Ravikumar et al. | Apr 2011 | A1 |
20110098792 | Lowe et al. | Apr 2011 | A1 |
20110098793 | Lowe et al. | Apr 2011 | A1 |
20110101117 | Miyauchi | May 2011 | A1 |
20110106023 | Lowe | May 2011 | A1 |
20110152982 | Richardson | Jun 2011 | A1 |
20110152983 | Schirrmacher et al. | Jun 2011 | A1 |
20110307038 | Stiehr et al. | Dec 2011 | A1 |
20120116272 | Hampton et al. | May 2012 | A1 |
20120143111 | Bledsoe et al. | Jun 2012 | A1 |
20120172774 | Lowe et al. | Jul 2012 | A1 |
20120179084 | Lipshaw et al. | Jul 2012 | A1 |
20120233736 | Tepper et al. | Sep 2012 | A1 |
20120245483 | Lundqvist | Sep 2012 | A1 |
20120288848 | Latham et al. | Nov 2012 | A1 |
20120330199 | Lurie et al. | Dec 2012 | A1 |
20130006154 | Lowe | Jan 2013 | A1 |
20130006335 | Lowe | Jan 2013 | A1 |
20130012847 | Lowe et al. | Jan 2013 | A1 |
20130013033 | Lowe | Jan 2013 | A1 |
20130123890 | Latham | May 2013 | A1 |
20130190553 | Wong et al. | Jul 2013 | A1 |
20130245519 | Edelman et al. | Sep 2013 | A1 |
20130245729 | Edelman et al. | Sep 2013 | A1 |
20130331914 | Lee et al. | Dec 2013 | A1 |
20140014292 | Rice | Jan 2014 | A1 |
20140046232 | Sham et al. | Feb 2014 | A1 |
20140142473 | Lowe et al. | May 2014 | A1 |
20140222121 | Spence et al. | Aug 2014 | A1 |
20140243939 | Lowe et al. | Aug 2014 | A1 |
20150075764 | Goth | Mar 2015 | A1 |
20150150717 | Lowe et al. | Jun 2015 | A1 |
20150366703 | Du | Dec 2015 | A1 |
20160038336 | Hilton et al. | Feb 2016 | A1 |
20160128865 | Lowe | May 2016 | A1 |
20160166428 | Hilton et al. | Jun 2016 | A1 |
20160350509 | Sharma | Dec 2016 | A1 |
20170145834 | Lewis | May 2017 | A1 |
20170299238 | Hepp et al. | Oct 2017 | A1 |
Number | Date | Country |
---|---|---|
2304378 | Jan 1999 | CN |
1373649 | Oct 2002 | CN |
2880025 | Mar 2007 | CN |
201001805 | Jan 2008 | CN |
201070419 | Jun 2008 | CN |
101524301 | Sep 2009 | CN |
3343664 | Mar 1985 | DE |
3505274 | Aug 1986 | DE |
3637841 | Feb 1988 | DE |
4445627 | Jun 1996 | DE |
202004008515 | Sep 2004 | DE |
102006053451 | May 2008 | DE |
102006053452 | May 2008 | DE |
102010022799 | Dec 2011 | DE |
102010052449 | May 2012 | DE |
102012002175 | Aug 2013 | DE |
0344949 | Dec 1989 | EP |
0412708 | Feb 1991 | EP |
0535830 | Apr 1993 | EP |
0861651 | Apr 2002 | EP |
1329676 | Jul 2003 | EP |
1393751 | Mar 2004 | EP |
1972312 | Sep 2008 | EP |
819022 | Oct 1937 | FR |
330552 | Oct 1935 | IT |
H08229061 | Sep 1996 | JP |
2000288007 | Oct 2000 | JP |
2002272773 | Sep 2002 | JP |
200153967 | Aug 1999 | KR |
100654317 | Dec 2006 | KR |
9213506 | Aug 1992 | WO |
9215263 | Sep 1992 | WO |
9409732 | May 1994 | WO |
9626693 | Sep 1996 | WO |
9721412 | Jun 1997 | WO |
9807397 | Feb 1998 | WO |
9944552 | Sep 1999 | WO |
0023016 | Apr 2000 | WO |
0055542 | Sep 2000 | WO |
0067685 | Nov 2000 | WO |
0154635 | Aug 2001 | WO |
0219954 | Mar 2002 | WO |
03072008 | Sep 2003 | WO |
2005082301 | Sep 2005 | WO |
2006110405 | Oct 2006 | WO |
2011019603 | Feb 2011 | WO |
2017223417 | Dec 2017 | WO |
Entry |
---|
Van Eps et al.; Equine laminitis: cryotherapy reduces the severity of the acute lesion; Equine Veterinary Journal; vol. 36; No. 3; pp. 255-260; Apr. 2004. |
Cothera LLC; VPULSE System Users Manual; 100149 Rev E; (C) 2013; 18 pgs. (manual rev. dated Jul. 2013). |
Van Eps et al.; distal limb cryotherapy for the prevention of acute laminitis; Clin Tech Equine Pract; vol. 3; pp. 64-70; Mar. 2004. |
International Search Report and Written Opinion for related PCT/US19/42720 dated Oct. 21, 2019. |
Number | Date | Country | |
---|---|---|---|
20170299238 A1 | Oct 2017 | US |
Number | Date | Country | |
---|---|---|---|
62321887 | Apr 2016 | US |